Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
J Appl Toxicol ; 39(11): 1586-1605, 2019 11.
Article in English | MEDLINE | ID: mdl-31415109

ABSTRACT

Food-grade titanium dioxide labeled as E171 has been approved for human consumption by the Food and Drug Administration (USA) and by the European Union for five decades. However, titanium dioxide has been classified as a possible carcinogen for humans by the International Agency of Research in Cancer raising concerns of its oral intake and the translocation to bloodstream, which could disturb barriers such as the blood-testis barrier. There is evidence that titanium dioxide by intragastric/intraperitoneal/intravenous administration induced alterations on testosterone levels, testicular function and architecture, but studies of the E171 effects on the testicle structure and blood-testis barrier are limited. E171 is contained not only in foods in liquid matrix but also in solid ones, which can exert different biological effects. We aimed to compare the effects of E171 consumption in a solid matrix (0.1%, 0.5% and 1% in pellets) and liquid suspension (5 mg/kg body weight) on testis structure, inflammation infiltrate and blood-testis barrier disruption of male BALB/c mice. Results showed that none of the administration routes had influence on body weight but an increase in germ cell sloughing and the infiltrate of inflammatory cells in seminiferous tubules, together with disruption of the blood-testis barrier were similar in testis of both groups even if the dose received in mice in liquid matrix was 136 or 260 times lower than the dose reached by oral intake in solid E171 pellets in 0.5% E171 and 1% E171, respectively. This study highlights the attention on matrix food containing E171 and possible adverse effects on testis when E171 is consumed in a liquid matrix.


Subject(s)
Blood-Testis Barrier/drug effects , Food Additives , Metal Nanoparticles/toxicity , Seminiferous Epithelium/drug effects , Sertoli Cells/drug effects , Titanium/toxicity , Animal Feed/analysis , Animals , Blood-Testis Barrier/immunology , Blood-Testis Barrier/pathology , Body Weight/drug effects , Dose-Response Relationship, Drug , Drinking Water/chemistry , Eating/drug effects , Food Additives/toxicity , Histocompatibility Antigens Class II/immunology , Male , Metal Nanoparticles/administration & dosage , Metal Nanoparticles/chemistry , Mice , Mice, Inbred BALB C , Particle Size , Seminiferous Epithelium/immunology , Seminiferous Epithelium/pathology , Seminiferous Tubules/drug effects , Seminiferous Tubules/immunology , Seminiferous Tubules/ultrastructure , Sertoli Cells/immunology , Sertoli Cells/ultrastructure , Surface Properties , Titanium/administration & dosage , Titanium/chemistry
2.
J Reprod Dev ; 59(5): 485-90, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23892333

ABSTRACT

Exposure to di-(2-ethylhexyl) phthalate (DEHP) has been reported to induce spermatogenic disturbance through oxidant stress and affect the immune system as an adjuvant. However, the effect of DEHP on the testicular immune microenvironment has not yet been investigated. In the present study, we examined the testicular immune microenvironment after exposure to doses of DEHP, previously identified as no-observed-adverse-effect levels. Adult male mice were administered food containing 0%, 0.01% or 0.1% DEHP and then testes were analyzed. The results showed that a slight but significant spermatogenic disturbance appeared in the 0.1% DEHP group but not in the 0.01% DEHP group at 8 weeks. It was also demonstrated that lymphocytes and F4/80- and MHC class II- positive cells were significantly increased with the elevation of IL-10 and IFN-γ mRNA expressions in the testes of not only the 0.1% DEHP group but also the 0.01% DEHP group at 8 weeks. Histochemical analyses involving horseradish peroxidase (HRP) as a tracer showed that a little blood-borne HRP had infiltrated into the lumen of a few seminiferous tubules beyond the blood-testis-barrier in both the 0.1% and 0.01% DEHP groups at 8 weeks. This indicates that a dose of DEHP that has little effects on spermatogenesis can change the testicular immune microenvironment with functional damage of the blood-testis barrier.


Subject(s)
Diethylhexyl Phthalate/toxicity , Immunity, Innate/drug effects , Immunity, Mucosal/drug effects , Immunomodulation/drug effects , Lymphocyte Activation/drug effects , Plasticizers/toxicity , Testis/drug effects , Animals , Blood-Testis Barrier/drug effects , Blood-Testis Barrier/metabolism , Cytokines/genetics , Cytokines/metabolism , Diethylhexyl Phthalate/administration & dosage , Dose-Response Relationship, Drug , Endocrine Disruptors/administration & dosage , Endocrine Disruptors/toxicity , Environmental Pollutants/administration & dosage , Environmental Pollutants/toxicity , Male , Mice , Mice, Inbred A , Oxidative Stress/drug effects , Plasticizers/administration & dosage , RNA, Messenger , Random Allocation , Seminiferous Epithelium/cytology , Seminiferous Epithelium/drug effects , Seminiferous Epithelium/immunology , Seminiferous Epithelium/metabolism , Spermatogenesis/drug effects , Testis/cytology , Testis/immunology , Testis/metabolism , Up-Regulation
3.
Am J Reprod Immunol ; 70(6): 509-17, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23848188

ABSTRACT

PROBLEM: The aim of this study was to identify the characteristics of serum autoantibodies in experimental autoimmune orchitis (EAO) induced by immunization with syngeneic testicular germ cells (TGC) alone in mice. METHOD OF STUDY: The serum autoantibodies were analyzed by enzyme-linked immunosorbent assay (ELISA), Western blotting, and immunohistochemical staining. RESULTS: Serum autoantibody titers against TGC and epididymal spermatozoa (ES) gradually increased with the development of EAO. At the initial stage of EAO, serum autoantibodies reacted with only a few antigens of TGC and ES, while in the later stage, the reactions with various antigens of TGC and ES occurred. However, the autoantibodies were specific to the testis and epididymis but not to other organs. CONCLUSION: These results indicate that titers and kinds of autoantibodies in TGC-immunized mice increase with EAO development and they are specific to TGC and ES.


Subject(s)
Autoantibodies/blood , Autoantibodies/immunology , Autoimmune Diseases/immunology , Orchitis/immunology , Spermatozoa/immunology , Testis/cytology , Animals , Autoimmune Diseases/pathology , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Male , Mice , Mice, Inbred Strains , Orchitis/pathology , Seminiferous Epithelium/immunology , Seminiferous Epithelium/pathology
4.
Med Mol Morphol ; 45(1): 35-44, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22431182

ABSTRACT

We previously established an immunological infertility model, experimental autoimmune orchitis (EAO), which can be induced by two subcutaneous injections of viable syngeneic testicular germ cells on days 0 and 14 in mice without using any adjuvant. In this EAO model, CD4+ T-cell-dependent lymphocytic infiltration and immune deposits were found with spermatogenic disturbance on day 120. However, the late stage of EAO (= postactive inflammation stage on day 365) has not yet been investigated. Therefore, we investigated the histopathological characteristics of the late stage. The results revealed that the lymphocytic infiltration finally resolved; however, the seminiferous epithelium persistently showed maturation arrest and the Sertoli cell-only feature. In the seminiferous tubules showing maturation arrest, both proliferation and apoptosis of germ cells had occurred simultaneously. It was also noted that there were deposits of immunoglobulin G and the third component of complement on the thickened basement membrane of seminiferous tubules in the late stage of EAO. These results indicate that histopathology after active inflammation in EAO comprises persistent damage to the seminiferous epithelium and may resemble the histopathology of "idiopathic disturbance of spermatogenesis" in man.


Subject(s)
Autoimmune Diseases/immunology , Autoimmune Diseases/physiopathology , Immunization , Orchitis/immunology , Orchitis/physiopathology , Spermatozoa/immunology , Spermatozoa/transplantation , Animals , CD4-Positive T-Lymphocytes/immunology , Disease Models, Animal , Humans , Infertility, Male/immunology , Infertility, Male/physiopathology , Inflammation , Injections, Subcutaneous , Male , Mice , Seminiferous Epithelium/immunology , Seminiferous Epithelium/pathology , Testis/immunology , Testis/pathology , Transplantation, Isogeneic
5.
Adv Exp Med Biol ; 763: 237-59, 2012.
Article in English | MEDLINE | ID: mdl-23397628

ABSTRACT

The blood-testis barrier (BTB) is known for its ability to create an immune privilege site in the seminiferous epithelium, but less is known of the blood-epididymal barrier (BEB). It is already established that the fully functional BTB and BEB are much more complex and consist of anatomical/physical (tight junctions, basolateral and apical membranes), physiological and immunological components, which are all necessary to make a functioning barrier in the testis and epididymis. However, comparative data for metazoans suggest that an effective Sertoli cell barrier is not entirely necessary for the development of germ cells during spermatogenesis or that our knowledge about the barrier structure/function in metazoans is still immature. This chapter compares the unique barrier formed by the Sertoli cells of the testis to that formed by the apical junctional complexes of the epididymal epithelium.


Subject(s)
Blood-Testis Barrier/immunology , Epididymis/immunology , Testis/immunology , Animals , Blood-Testis Barrier/anatomy & histology , Blood-Testis Barrier/physiology , Cell Differentiation , Cell Membrane Permeability , Epididymis/anatomy & histology , Epididymis/physiology , Graft Survival/immunology , Humans , Immune Tolerance , Male , Phylogeny , Seminiferous Epithelium/immunology , Seminiferous Epithelium/physiology , Sertoli Cells/immunology , Sertoli Cells/physiology , Sertoli Cells/ultrastructure , Sperm Maturation , Spermatogenesis , Spermatozoa/immunology , Spermatozoa/physiology , Testis/anatomy & histology , Testis/physiology , Tight Junctions/immunology , Tight Junctions/physiology , Tight Junctions/ultrastructure , Transplantation Immunology
6.
Microsc Microanal ; 17(6): 1002-14, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22047748

ABSTRACT

Transplantation of spermatogonial stem cells (SSCs), the male germline stem cells, in experimental animal models has been successfully used to study mechanisms involved in SSC self-renewal and to restore fertility. However, there are still many challenges associated with understanding the recipient immune response for SSCs use in clinical therapies. Here, we have undertaken a detailed structural study of macrophages elicited by SSCs transplantation in mice using both high-resolution light microscopy (HRLM) and transmission electron microscopy (TEM). We demonstrate that SSCs transplantation elicits a rapid and potent recruitment of macrophages into the seminiferous epithelium (SE). Infiltrating macrophages were derived from differentiation of peritubular monocyte-like cells into typical activated macrophages, which actively migrate through the SE, accumulate in the tubule lumen, and direct phagocytosis of differentiating germ cells and spermatozoa. Quantitative TEM analyses revealed increased formation of lipid bodies (LBs), organelles recognized as intracellular platforms for synthesis of inflammatory mediators and key markers of macrophage activation, within both infiltrating macrophages and Sertoli cells. LBs significantly increased in number and size in parallel to the augmented macrophage migration during different times post-transplantation. Our findings suggest that LBs may be involved with immunomodulatory mechanisms regulating the seminiferous tubule niche after SSC transplantation.


Subject(s)
Microscopy, Electron, Transmission/methods , Seminiferous Epithelium/ultrastructure , Seminiferous Tubules/ultrastructure , Sertoli Cells/ultrastructure , Spermatogonia/ultrastructure , Stem Cell Transplantation/methods , Stem Cells/immunology , Animals , Cell Count , Cell Differentiation , Cell Movement , Cell Proliferation , Cytokines/biosynthesis , Macrophages/cytology , Macrophages/immunology , Macrophages/ultrastructure , Male , Mice , Monocytes/cytology , Monocytes/immunology , Monocytes/ultrastructure , Organelles/immunology , Organelles/ultrastructure , Phagocytosis/immunology , Seminiferous Epithelium/immunology , Seminiferous Tubules/immunology , Sertoli Cells/immunology , Spermatogenesis , Spermatogonia/cytology , Spermatogonia/immunology , Spermatogonia/transplantation , Stem Cells/cytology , Time Factors
7.
J Reprod Immunol ; 88(2): 130-41, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21333360

ABSTRACT

It is self-evident that infection and inflammation in the reproductive tract can inhibit male fertility, but the observation that fertility may also be compromised by systemic inflammation and disease is more difficult to explain. Recent studies implicating microbial pattern-recognition receptors, such as the Toll-like receptors (TLRs), as well as inflammatory cytokines and their signalling pathways, in testicular function have cast new light on this mysterious link between infection/inflammation and testicular dysfunction. It is increasingly evident that signalling pathways normally involved in controlling inflammation play fundamental roles in regulating Sertoli cell activity and responses to reproductive hormones, in addition to promoting immune responses within the testis. Many of the negative effects of inflammation on spermatogenesis may be attributed to elevated production of inflammation-related gene products within the circulation and the testis, which subsequently exert disruptive effects on spermatogenic cell development and survival, as well as the ability of the Sertoli cells to provide support for spermatogenesis. These interactions have important implications for testicular dysfunction and disease, and may eventually provide new opportunities for therapeutic interventions.


Subject(s)
Infertility, Male/immunology , Seminiferous Epithelium/immunology , Sertoli Cells/immunology , Testis/immunology , Toll-Like Receptors/immunology , Animals , Humans , Infertility, Male/therapy , Inflammation , Inflammation Mediators/immunology , Male , Signal Transduction/immunology , Spermatogenesis/immunology , Testis/pathology
8.
Reproduction ; 137(5): 879-88, 2009 May.
Article in English | MEDLINE | ID: mdl-19225044

ABSTRACT

The luminal part of the seminiferous epithelium, a tissue compartment protected by the blood-testis barrier, has been considered a site of immune privilege. However, there are reports describing the production of anti-microbial peptides and the expression of Toll-like receptors in cells present in the seminiferous epithelium, evoking the possibility that this tissue compartment is immunologically active at least with regard to the innate immune response. To test this, we injected Escherichia coli into seminiferous tubules of live mice and examined the fate of bacteria, the production of chemokines and inflammatory cytokines, and the infiltration of neutrophils. The bacteria actively propagated and reached a maximal level in a day, but started to decrease after 5 days and completely disappeared in 2 months. The expression of macrophage inflammatory protein-2 and tumor necrosis factor-alpha became evident in macrophages present in the interstitial compartment of testes as early as 1-3 h after the inoculation of bacteria. Neutrophils first accumulated in the interstitial space at 9-12 h and entered the tubules after a day. On the other hand, impairment of spermatogenesis was observed a day after bacteria injection and seemed unrecoverable even after the bacteria were eliminated. By contrast, bacteria injected into the interstitial compartment were more rapidly cleared with no damage in the seminiferous epithelium. These results suggest the existence of immunity against invading microbes in the seminiferous epithelium although its effectiveness in maintaining tissue homeostasis remains equivocal.


Subject(s)
Escherichia coli/immunology , Seminiferous Epithelium/immunology , Seminiferous Epithelium/microbiology , Animals , Bacterial Load , Chemokine CXCL2/genetics , Chemokine CXCL2/metabolism , Escherichia coli/growth & development , Gene Expression Regulation , Inflammation Mediators/metabolism , Macrophages/immunology , Macrophages/microbiology , Male , Mice , Neutrophil Infiltration , Neutrophils/immunology , Neutrophils/microbiology , Spermatogenesis , Time Factors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
9.
Int J Androl ; 30(1): 21-7, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17328721

ABSTRACT

The tubuli recti (TR) are immunologically special, because the lymphocytes preferably accumulate around them during the course of T-cell dependent testicular autoimmunity in mice. This finding implies that the testicular interstitium around the TR is where autoreactive lymphocytes can gain access to autoimmunogenic germ cell antigens. In the present study, the histoarchitecture of the TR was minutely examined in normal mice. Three-dimensional analysis showed that 14-16 TR appeared to be connected to the rete testis (RT). Electron microscopical analysis revealed that the epithelial cells in the TR formed protruding cytoplasmic strings, with active endocytosis of degenerated spermatozoa, and exhibited three different morphological characteristics. Furthermore, a few macrophages were found to have penetrated into the TR. Immunohistochemical image analysis revealed that more macrophages specifically accumulated around the TR than the RT or seminiferous tubules. These findings indicate that macrophages preferentially accumulate around the TR, where contact between germ cell antigens and macrophages may occur under normal and pathological conditions.


Subject(s)
Leydig Cells/immunology , Leydig Cells/ultrastructure , Lymphocytes/immunology , Rete Testis/immunology , Rete Testis/ultrastructure , Animals , Endocytosis , Macrophages/immunology , Male , Mice , Mice, Inbred ICR , Seminiferous Epithelium/cytology , Seminiferous Epithelium/immunology , Spermatozoa/cytology , Spermatozoa/immunology
10.
J Reprod Immunol ; 69(1): 23-34, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16380167

ABSTRACT

On most tissues, multiple membrane complement regulators (CReg) protect self-cells from damage by complement. An exception is the brain, where the blood-brain barrier provides a protected environment within which cells survive with little or no protection from complement. The testis has a functionally similar structure, the blood-testis barrier (BTB). Here, we have investigated the expression of C3/C5 convertase CReg and C3 in the normal rat testis at different ages and different spermatogenetic stages, as well as in rats in which spermatogenesis and the BTB were impaired due to a developmental deficit. Immature testis, prior to BTB formation at puberty, displayed broad expression of the ubiquitous rodent CReg Crry on all elements and no expression of CD46 or CD55. Within days of BTB formation, CReg expression was dramatically altered; Crry was expressed only in the spermatogenetic cells external to the BTB in basal layers of adult seminal epithelium. Spermatogenic cells immediately distal to the BTB at first expressed no C3/C5 convertase regulators but later acquired expression of CD46 and CD55. Staining for C3 was widespread pre-puberty, but absent distal to the BTB in mature rats. In rats with defects in spermatogenesis and BTB integrity, expression patterns of CReg and C3 resembled those in pre-pubertal normals. The relative paucity of CReg and absence of C3 synthesis distal to the BTB suggest the presence of a complement-protected environment analogous to that described in the brain, and suggest also that cells enclosed by the BTB may be susceptible to complement damage when the barrier is breached.


Subject(s)
Blood-Testis Barrier/immunology , Complement C3/metabolism , Complement Inactivator Proteins/metabolism , Spermatogenesis , Testis/growth & development , Testis/immunology , Animals , Complement C3/analysis , Complement C3-C5 Convertases/metabolism , Complement Inactivator Proteins/analysis , Complement Inactivator Proteins/genetics , Male , Mutation , Rats , Rats, Wistar , Seminiferous Epithelium/chemistry , Seminiferous Epithelium/growth & development , Seminiferous Epithelium/immunology , Spermatogenesis/genetics , Testis/cytology
12.
APMIS ; 107(4): 431-6, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10230699

ABSTRACT

Sixteen seminomas with surrounding tissue containing normal and precancerous (cis) seminiferous tubules were examined for the expression of Fas (CD95, APO-1) and Fas ligand (FasL) (CD95L). This was done by analyzing frozen specimens using immunohistochemistry with antibodies directed against Fas and FasL. The study showed that varying numbers (mean approx. 20%) of Fas-positive lymphocytes were present among tumor-infiltrating lymphocytes, but very few FasL-positive lymphocytes. Fas was not expressed by normal seminiferous tubules and only occasional Fas-positive epithelial cells were seen in cis tubules. FasL was expressed in 9 out of 10 cases in virtually all normal seminiferous tubules, mainly as a thin layer at the base of the seminiferous epithelium. In precancerous tubules, this layer was discontinuous and less pronounced. Rete testis expressed FasL in 2 out of 2 cases with rete present and Fas in 1 out of 1 case. Invasive tumor cells did not express Fas or FasL. The data are discussed in relation to immune reactions to seminomas and to the concept of the testis being an immunologically privileged area.


Subject(s)
Antigens, Neoplasm/analysis , Antigens, Surface/analysis , Gene Expression Regulation, Neoplastic , Lymphocytes/immunology , Membrane Glycoproteins/analysis , Seminoma/immunology , Testicular Neoplasms/immunology , fas Receptor/analysis , Fas Ligand Protein , Humans , Immunohistochemistry , Lymphocyte Activation , Male , Seminiferous Epithelium/immunology
13.
Andrologia ; 25(5): 301-5, 1993.
Article in English | MEDLINE | ID: mdl-8250294

ABSTRACT

Ki-67 expression in the seminiferous tubule of the bovine testis was studied by immunohistochemistry during the seminiferous epithelial cycle using the monoclonal antibody MIB-1. Spermatogonial proliferation is most obvious in stages 5-7, and 8, when B-spermatogonia divide. A lower rate of spermatogonial propagation is observed preceding or during meiosis in stages 1-4. The MIB-1 antibody also gives positive results with some post-spermatogonial tubular cells. Preleptotenes passing through S-phase in stage 1 reveal positive nuclei. During prophase of meiosis I pachytenes react strongly, diplotenes react in an attenuated manner, while leptotenes and zygotenes stay negative. Secondary spermatocytes seen in stage 4 are positive as are the chromosomes during meta- and anaphase of the meiotic divisions. Post-meiotic spermatids are also decorated but stop Ki-67 expression abruptly at the end of stage 4. Sertoli cells are negative.


Subject(s)
Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , Seminiferous Tubules/metabolism , Animals , Antibodies, Monoclonal , Antigens/metabolism , Cattle , Cell Division , Immunohistochemistry , Ki-67 Antigen , Male , Neoplasm Proteins/immunology , Nuclear Proteins/immunology , Seminiferous Epithelium/cytology , Seminiferous Epithelium/immunology , Seminiferous Epithelium/metabolism , Seminiferous Tubules/cytology , Seminiferous Tubules/immunology , Spermatogenesis/immunology , Spermatogenesis/physiology
14.
Biol Reprod ; 44(5): 814-21, 1991 May.
Article in English | MEDLINE | ID: mdl-1868140

ABSTRACT

The distribution of the sperm protein SP-10 was investigated in plastic-embedded samples of human testes by light and electron microscopy. An immunogold and silver enhancement technique, in conjunction with a monoclonal antibody (MHS-10) raised against SP-10, was used to localize the protein. SP-10 was detected in spermatids at each of the six stages of the cycle of the seminiferous epithelium. Light microscopy showed immunoreactive material at the circumference of developing acrosomes in the early steps of spermiogenesis. As differentiation proceeded and cell shape changed from round to elongated, immunoreactive material appeared in an arc, which gradually became a V shape bordering the spermatid nucleus. The area of the immunoreactive material and its shape corresponded to that of the developing acrosome. At the electron microscopic level, gold particles indicative of the presence of SP-10 were detected on electron-dense material found within the developing acrosomal vesicle in early steps of spermiogenesis. As the electron density of the acrosome increased, a high concentration of gold particles was seen in the vesicle matrix. The gold particles gradually became associated with the inner and outer acrosomal membranes of the most mature spermatids.


Subject(s)
Antigens/metabolism , Gonadal Steroid Hormones/metabolism , Seminiferous Epithelium/immunology , Spermatozoa/immunology , Acrosome/immunology , Acrosome/ultrastructure , Humans , Immunohistochemistry , Male , Membrane Proteins , Microscopy, Immunoelectron , Seminiferous Epithelium/physiology , Seminiferous Epithelium/ultrastructure , Spermatids/immunology , Spermatids/ultrastructure , Spermatogenesis/immunology , Spermatozoa/ultrastructure
15.
Fertil Steril ; 27(8): 971-4, 1976 Aug.
Article in English | MEDLINE | ID: mdl-955138

ABSTRACT

The extraction of antigen from testis and sperm is described. This antigen, when administered in microgram amounts in a single injection, induces aspermatogenesis in 100% of guinea pigs so treated. The deletion of the seminiferous cell line is specific (no cross-reactions) and provides a tool for investigating inhibition of cell replication as well as reproductive control. The antigen is a polypeptide-polysaccharide complex and has been determined to have a molecular weight of 10,520, using the equilibrium ultracentrifugation method.


Subject(s)
Antigens , Spermatogenesis , Animals , Cell Line , Guinea Pigs , Male , Molecular Weight , Seminiferous Epithelium/immunology , Ultracentrifugation
SELECTION OF CITATIONS
SEARCH DETAIL
...